101 – 110 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series
(
- Contribution to journal › Article
-
Mark
Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients
(
- Contribution to journal › Article
-
Mark
Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics
(
- Contribution to journal › Article
-
Mark
Survival of children with liver tumours in Europe 1978--1989
(
- Contribution to journal › Article
-
Mark
Genetic epidemiology of BRCA1 mutations in Norway
(
- Contribution to journal › Article
- 2000
-
Mark
Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol
(
- Contribution to journal › Article
-
Mark
Accrual rate-limiting factors in a Swedish randomised ductal carcinoma in situ (DCIS) trial - a demographic study
(
- Contribution to journal › Article
-
Mark
Prognosis and clinical presentation of BRCA2-associated breast cancer
(
- Contribution to journal › Article
-
Mark
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients
(
- Contribution to journal › Article